We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBCP:NASDAQIndependent Bank Corporation Analysis

Data as of 2026-04-09 - not real-time

$34.47

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Independent Bank Corporation (IBCP) is trading at $34.47, roughly 7% below its DCF‑derived fair value of $36.26, suggesting modest upside. The stock’s 20‑day SMA ($33.12) sits just below the current price while the 50‑day SMA ($34.63) is slightly above, indicating a near‑term consolidation zone. Technical momentum is mixed: the RSI at 59 points to a neutral stance, yet the MACD histogram is positive (0.25) with a bullish signal line crossover. Volume has been decreasing, which could limit short‑term price moves. The beta of 0.74 and 30‑day volatility of 22% place IBCP in a lower‑risk profile than many growth stocks. Fundamentally, the P/E of 10.5 is well under the industry average of 17.3, and the dividend yield of 3.25% with a 31.8% payout ratio supports income appeal.
Recent material news includes a $70.2 million cash‑and‑stock acquisition of HCB Financial, expanding IBCP’s footprint in the high‑growth Grand Rapids‑Lansing corridor. The company also launched a 2026 share‑repurchase plan, signaling confidence in its balance sheet. A pending class‑action investigation adds a legal risk, but the exposure appears limited at this stage. With operating margins of 37.5% and a solid ROE of 14.3%, earnings are resilient despite a 5.6% revenue decline last year. The combination of undervaluation, strong dividend sustainability, and strategic growth initiatives makes IBCP a compelling value play. Investors should monitor the upcoming Q1 earnings release for clues on integration progress and loan‑portfolio performance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Neutral RSI with bullish MACD histogram
  • Price near support with modest upside to DCF
  • Upcoming earnings and acquisition integration risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to fair value and industry P/E
  • Attractive 3.25% dividend yield with low payout ratio
  • Strategic acquisition expanding market presence

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend supported by solid earnings and cash flow
  • Low beta and stable profitability indicating defensive profile
  • Long‑term growth potential from regional banking fundamentals and expansion

Key Metrics & Analysis

Financial Health

Revenue Growth-5.60%
Profit Margin31.22%
P/E Ratio10.5
ROE14.31%
ROA1.26%
P/B Ratio1.4
Op. Cash Flow$76.7M
Industry P/E17.3

Technical Analysis

TrendNeutral
RSI59.1
Support$31.75
Resistance$35.07
MA 20$33.12
MA 50$34.63
MA 200$32.92
MACDBullish
VolumeDecreasing
Fear & Greed Index83.45

Valuation

Fair Value$36.26
Target Price$37.00
Upside/Downside7.34%
GradeUndervalued
TypeValue
Dividend Yield3.25%

Risk Assessment

Beta0.74
Volatility22.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.